Warning letter
Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy: warning letter of Mar 31, 2020
FDA warning letter 606489 · Division of Pharmaceutical Quality Operations IV
Key facts
| Reference number | 606489 |
|---|---|
| Company | Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy |
| Subject | Compounding Pharmacy/Adulterated Drug Products |
| Issue date | Mar 31, 2020 |
| Posted date | Apr 28, 2020 |
| Issuing office | Division of Pharmaceutical Quality Operations IV |
| Product type | Drugs |
| CFR sections cited | 211.167(a), 201.115, 200.10(b), 211.42(c)(10), 211.42(c)(10)(v), 211.67(a), 211.84(d)(2), 211.113(b), 211.165(a), 211.166(a), 210.1(b) |
| Inspection city | Corvallis |
| Inspection ZIP | 97330 |
| Inspection start date | Dec 10, 2018 |
| Letter on fda.gov | fda.gov |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: